Cellectis (CLLS) Amortization (2023 - 2025)

Cellectis (CLLS) has 3 years of Amortization data on file, last reported at $2.0 billion in Q3 2025.

• In Q3 2025, Amortization changed 0.05% year-over-year to $2.0 billion; the TTM figure through Sep 2025 stood at $8.1 billion (changed 0.02% YoY), while the FY2024 annual figure was $2.0 million, changed N/A from the prior year.
• Amortization improved to $2.0 billion in Q3 2025, from $2.0 million in the prior quarter.
• Across five years, Amortization topped out at $2.0 billion in Q3 2025 and bottomed at $2.0 million in Q4 2024.
• A 3-year average of $1.7 billion and a median of $2.0 billion in 2023 frame the typical range for Amortization.
• Annual changes were most pronounced in 2024 — Amortization rose 0.05% — and 2025, when it gained 0.05%.
• Year by year, Amortization stood at $2.0 billion in 2023, then plunged by 99.9% to $2.0 million in 2024, then surged by 99949.41% to $2.0 billion in 2025.
• The last three Amortization figures came in at $2.0 billion (Q3 2025), $2.0 million (Q4 2024), and $2.0 billion (Q3 2024), per Business Quant data.

Peer Comparison